Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non 24 Hour Sleep Wake Disorder”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Post-approval studies (Phase 4)Study completedNCT02130999
What this trial is testing

Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)

Who this might be right for
Non-24-Hour-Sleep-Wake Disorder
Vanda Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT00972075
What this trial is testing

Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects

Who this might be right for
Non-24 Hour Sleep-Wake DisorderBlindness
Neurim Pharmaceuticals Ltd. 13
Large-scale testing (Phase 3)Study completedNCT01430754
What this trial is testing

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

Who this might be right for
Non-24-Hour Sleep-Wake Disorder
Vanda Pharmaceuticals 20
Large-scale testing (Phase 3)Active Not RecruitingNCT01218789
What this trial is testing

Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception

Who this might be right for
Non 24 Hour Sleep Wake Disorder
Vanda Pharmaceuticals 140
Large-scale testing (Phase 3)Study completedNCT01163032
What this trial is testing

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

Who this might be right for
Non-24-Hour Sleep-Wake Disorder
Vanda Pharmaceuticals 136
Early research (Phase 1)Study completedNCT02776215
What this trial is testing

Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents

Who this might be right for
Circadian Rhythm Sleep DisordersNon-24 Hour Sleep-Wake DisorderAutism Spectrum Disorder+1 more
Vanda Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT01429116
What this trial is testing

Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

Who this might be right for
Non-24-Hour Sleep-Wake Disorder
Vanda Pharmaceuticals 200
Not applicableEnded earlyNCT03956745
What this trial is testing

Biomarkers for Circadian Timing in Healthy Adults

Who this might be right for
Sleep Wake DisordersSleep Disorders, Circadian RhythmSleep Disorders, Intrinsic+10 more
Brigham and Women's Hospital 15
Not applicableEnded earlyNCT03980340
What this trial is testing

Breath Biomarkers for Sleep Loss and Circadian Timing

Who this might be right for
Shift-Work Sleep DisorderShift Work Type Circadian Rhythm Sleep DisorderSleep Disorders, Circadian Rhythm+8 more
Brigham and Women's Hospital 5